The 65th Annual Employee Benefits Conference is the largest gathering of multiemployer and public employee benefit plan representatives. This must-attend event offers you the opportunity to network with your peers, be surrounded by industry experts and learn the latest in the industry so you can make the most informed decisions on behalf of your funds.

With topics ranging from legal and legislative to health and welfare to retirement security, the Annual Employee Benefits Conference is the educational event to attend for most current information and perspectives from leading industry experts on all areas of employee benefits. With so many options to choose from, the Annual Conference is like attending several conferences all rolled into one! Don’t miss the event of the year!

WellDyneRx will be exhibiting at booth #629.

Healthcare is experiencing a major paradigm shift, moving away from fee-for-service to pay-for-performance. With this paradigm shift, there have been many opinions on how to measure performance. Traditionally, healthcare quality was measured using biomarkers associated with improvement of disease state. These measures, while important, do not accurately provide the entire continuum of quality healthcare. Over the past several years, a greater focus is shifting to incorporate patient reported outcomes (PROs) into the overall measurement of healthcare performance. In addition, payers are interested in incorporating real-world evidence (RWE) in formulary management, which provides a clearer picture of the impact of a medication on patient outcomes. This presentation will describe the differences between PROs, RWE, and other quality measures. Attendees will gain insight regarding how payers can leverage information from PROs and RWE to effectively review and manage formularies. Additionally, we will demonstrate how specialty pharmacies can be at the forefront generating real-world evidence and obtaining PROs and how they can apply this information to improve clinical practice. In addition, payers are interested in incorporating real-world evidence (RWE) in formulary management, which provides a clearer picture of the impact of a medication on patient outcomes. This presentation will describe the differences between PROs, RWE, and other quality measures. Attendees will gain insight regarding how payers can leverage information from PROs and RWE to effectively review and manage formularies. Additionally, we will demonstrate how specialty pharmacies can be at the forefront generating real-world evidence and obtaining PROs and how they can apply this information to improve clinical practice. Presenters are Patty Taddei-Allen, PharmD, MBA and Nick Page, PharmD.

The Academy of Managed Care Pharmacy (AMCP) is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. Through evidence- and value-based strategies and practices, the Academy’s 8,000 pharmacists, physicians, nurses and other practitioners manage medication therapies for the 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models and government. WellDyneRx will be exhibiting at booth #610.